中央性弥散减低征鉴别治疗相关病变与胶质瘤进展的验证研究
本研究纳入231例因疑似胶质瘤复发手术的患者,最终103例(治疗相关病变22例、肿瘤进展81例)按组织病理学诊断,由两位神经放射学家将术前MR弥散模式分为5类。以中央性弥散减低模式预测治疗相关病变的敏感度为64%、特异度为84%、阳性预测值为52%、阴性预测值为89%;无中央性弥散减低时组织学诊断为治疗相关病变的概率低(11%)。
要点
- 中央性弥散减低征与治疗效应存在相关,特异度84%、阴性预测值89%。
- 无中央性弥散减低时,组织学诊断为治疗相关病变的概率低(11%)。
- 中央性弥散减低征敏感度64%,阳性预测值52%,不能单独排除肿瘤进展。
关键影像表现/征象
- 弥散模式分为5类:仅实性成分弥散减低、主要位于实性成分的弥散减低、无弥散减低、主要位于中央坏死的弥散减低、仅中央坏死区弥散减低。
- 中央性弥散减低模式(「主要中央」与「完全中央」模式对比所有其他模式)预测治疗相关病变的敏感度为64%(95%CI 41%-83%)。
- 中央性弥散减低模式预测治疗相关病变的特异度为84%(95%CI 74%-91%)、阳性预测值为52%(95%CI 37%-66%)、阴性预测值为89%(95%CI 83%-94%)。
诊断标准与关键数值
- 中央性弥散减低模式定义为「主要中央」和「完全中央」模式对比所有其他模式。
- 以组织病理学报告为参考标准,中央性弥散减低模式预测治疗相关病变的敏感度为64%(95%CI 41%-83%)、特异度为84%(95%CI 74%-91%)、阳性预测值为52%(95%CI 37%-66%)、阴性预测值为89%(95%CI 83%-94%)。
- 无中央性弥散减低时,组织学诊断为治疗相关病变的概率为11%。
临床应用与阅片要点
- 作者认为中央性弥散减低征与治疗效应存在相关。
- 作者指出无中央性弥散减低时组织学诊断为治疗相关病变的概率低(11%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Differentiating between treatment-related lesions and tumor progression remains one of the greatest dilemmas in neuro-oncology. Diffusion MR imaging characteristics may provide useful information to help make this distinction. The aim of the study was to assess the diagnostic accuracy of the centrally reduced diffusion sign for differentiation of treatment-related lesions and true tumor progression in patients with suspected glioma recurrence.
MATERIALS AND METHODS: The images of 231 patients who underwent an operation for suspected glioma recurrence were reviewed. Patients with susceptibility artifacts or without central necrosis were excluded. The final diagnosis was established according to histopathology reports. Two neuroradiologists classified the diffusion patterns on preoperative MR imaging as the following: 1) reduced diffusion in the solid component only, 2) reduced diffusion mainly in the solid component, 3) no reduced diffusion, 4) reduced diffusion mainly in the central necrosis, and 5) reduced diffusion in the central necrosis only. Diagnostic accuracy metrics and the area under the receiver operating characteristic curve were estimated for the diffusion patterns.
RESULTS: One hundred three patients were included (22 with treatment-related lesions and 81 with tumor progression). The diagnostic accuracy results for the centrally reduced diffusion pattern as a predictor of treatment-related lesions ("mainly central" and "exclusively central" patterns versus all other patterns) were as follows: 64% sensitivity (95% CI, 41%-83%), 84% specificity (95% CI, 74%-91%), 52% positive predictive value (95% CI, 37%-66%), and 89% negative predictive value (95% CI, 83%-94%).
CONCLUSIONS: The centrally reduced diffusion sign is associated with the presence of treatment effect. The probability of a histologic diagnosis of a treatment-related lesion is low (11%) in the absence of centrally reduced diffusion.
引用
- Alcaide-Leon P, Cluceru J, Lupo JM, et al. Centrally Reduced Diffusion Sign for Differentiation between Treatment-Related Lesions and Glioma Progression: A Validation Study. AJNR Am J Neuroradiol. 2020. PMID: 33060101. doi:10.3174/ajnr.A6843
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。